IT8003429A0 - Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica - Google Patents

Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Info

Publication number
IT8003429A0
IT8003429A0 IT8003429A IT342980A IT8003429A0 IT 8003429 A0 IT8003429 A0 IT 8003429A0 IT 8003429 A IT8003429 A IT 8003429A IT 342980 A IT342980 A IT 342980A IT 8003429 A0 IT8003429 A0 IT 8003429A0
Authority
IT
Italy
Prior art keywords
riphamic
imidazo
substance
preparation
antibacterial action
Prior art date
Application number
IT8003429A
Other languages
English (en)
Other versions
IT1154655B (it
Inventor
Egidio Marchi Lauret Montecchi
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of IT8003429A0 publication Critical patent/IT8003429A0/it
Priority to IT03429/80A priority Critical patent/IT1154655B/it
Priority to NLAANVRAGE8102290,A priority patent/NL187022C/xx
Priority to US06/262,123 priority patent/US4341785A/en
Priority to AU70655/81A priority patent/AU537093B2/en
Priority to AT0222781A priority patent/AT373599B/de
Priority to EG280/81A priority patent/EG14891A/xx
Priority to PH25656A priority patent/PH17207A/en
Priority to FR8110058A priority patent/FR2482967A1/fr
Priority to LU83376A priority patent/LU83376A1/fr
Priority to PT73064A priority patent/PT73064B/pt
Priority to GR65010A priority patent/GR75640B/el
Priority to SE8103216A priority patent/SE453089B/sv
Priority to FI811565A priority patent/FI69467C/fi
Priority to ES502906A priority patent/ES8203388A1/es
Priority to CA000378015A priority patent/CA1142518A/en
Priority to BE2/59169A priority patent/BE888895A/fr
Priority to DK224781A priority patent/DK157876C/da
Priority to NO811731A priority patent/NO155622C/no
Priority to ZA00813430A priority patent/ZA813430B/xx
Priority to IE1139/81A priority patent/IE51204B1/en
Priority to CH3381/81A priority patent/CH648037A5/de
Priority to AR285424A priority patent/AR226212A1/es
Priority to DE19813120460 priority patent/DE3120460A1/de
Priority to JP7787781A priority patent/JPS5711987A/ja
Priority to GB8115790A priority patent/GB2079270B/en
Priority to PH26842A priority patent/PH18704A/en
Application granted granted Critical
Publication of IT1154655B publication Critical patent/IT1154655B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT03429/80A 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica IT1154655B (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
NLAANVRAGE8102290,A NL187022C (nl) 1980-05-22 1981-05-11 Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
US06/262,123 US4341785A (en) 1980-05-22 1981-05-11 Imidazo-rifamycin derivatives with antibacterial utility
AU70655/81A AU537093B2 (en) 1980-05-22 1981-05-18 New imidazo-rifamycin derivatives with antibacterial utility
AT0222781A AT373599B (de) 1980-05-22 1981-05-19 Verfahren zur herstellung neuer rifamycinderivate
EG280/81A EG14891A (en) 1980-05-22 1981-05-20 A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility
PH25656A PH17207A (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility
FR8110058A FR2482967A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique
LU83376A LU83376A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
PT73064A PT73064B (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with anti-bacterial utility
GR65010A GR75640B (it) 1980-05-22 1981-05-20
FI811565A FI69467C (fi) 1980-05-22 1981-05-21 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrido- och isokinolin(1',2':1,2)imidazo(5,4-c)rifamycin soch sv-derivat
SE8103216A SE453089B (sv) 1980-05-22 1981-05-21 Imidazo-rifamycinderivat, forfarande for framstellning derav och farmaceutisk komposition
ES502906A ES8203388A1 (es) 1980-05-22 1981-05-21 Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
CA000378015A CA1142518A (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives with antibacterial utility
BE2/59169A BE888895A (fr) 1980-05-22 1981-05-21 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
DK224781A DK157876C (da) 1980-05-22 1981-05-21 Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
NO811731A NO155622C (no) 1980-05-22 1981-05-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido- og isokinolin (1[,2[:1,2) imidazo (5,4-c) rifamycin sv og s derivater.
ZA00813430A ZA813430B (en) 1980-05-22 1981-05-21 New imidazo-rifamycin derivatives with antibacterial utility
IE1139/81A IE51204B1 (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives
CH3381/81A CH648037A5 (de) 1980-05-22 1981-05-22 Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
AR285424A AR226212A1 (es) 1980-05-22 1981-05-22 Procedimiento para preparar nuevos derivados de imidazo rifamicina
DE19813120460 DE3120460A1 (de) 1980-05-22 1981-05-22 Pyridoimidazolorifamycinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP7787781A JPS5711987A (en) 1980-05-22 1981-05-22 Novel imidazo-rifamycin derivative
GB8115790A GB2079270B (en) 1980-05-22 1981-05-22 Imidazo-rifamycin derivatives
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (2)

Publication Number Publication Date
IT8003429A0 true IT8003429A0 (it) 1980-05-22
IT1154655B IT1154655B (it) 1987-01-21

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Country Status (25)

Country Link
US (1) US4341785A (it)
JP (1) JPS5711987A (it)
AR (1) AR226212A1 (it)
AT (1) AT373599B (it)
AU (1) AU537093B2 (it)
BE (1) BE888895A (it)
CA (1) CA1142518A (it)
CH (1) CH648037A5 (it)
DE (1) DE3120460A1 (it)
DK (1) DK157876C (it)
EG (1) EG14891A (it)
ES (1) ES8203388A1 (it)
FI (1) FI69467C (it)
FR (1) FR2482967A1 (it)
GB (1) GB2079270B (it)
GR (1) GR75640B (it)
IE (1) IE51204B1 (it)
IT (1) IT1154655B (it)
LU (1) LU83376A1 (it)
NL (1) NL187022C (it)
NO (1) NO155622C (it)
PH (2) PH17207A (it)
PT (1) PT73064B (it)
SE (1) SE453089B (it)
ZA (1) ZA813430B (it)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
EP0861660B9 (en) * 1997-02-28 2006-06-28 Kaneka Corporation Curative medicine for disease caused by infection of Helicobacter
JP2005510534A (ja) * 2001-11-21 2005-04-21 アクティブバイオティクス インコーポレイティッド 標的化治療薬およびその使用
WO2003051299A2 (en) * 2001-12-13 2003-06-26 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
ATE552824T1 (de) * 2002-11-05 2012-04-15 Fadim S R L Kontrollierte und kontinuierliche verabreichung von rifaximin
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
EP1928890B1 (en) 2005-08-11 2013-04-03 Targanta Therapeutics Inc. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
ES2747259T3 (es) 2006-03-09 2020-03-10 Salix Pharmaceuticals Inc Preparación anti-disfunción rectal de rifaximina
JP5844961B2 (ja) 2006-08-02 2016-01-20 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線直腸ｓ状結腸炎を処置するための組成物および方法
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
EP2069363B1 (en) * 2006-09-22 2013-03-20 Cipla Ltd. Rifaximin in an amorphous form
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
EP2420226B1 (en) 2007-07-06 2020-03-04 Lupin Limited Pharmaceutical compositions of rifaximin
AU2008273699A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
WO2009108730A2 (en) 2008-02-25 2009-09-03 Salix Pharmaceuticals, Ltd. Forms of rifaximin and uses thereof
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
ES2727728T3 (es) 2008-02-26 2019-10-18 Salix Pharmaceuticals Ltd Métodos para el tratamiento del síndrome del intestino irritable
PL2294012T3 (pl) 2008-05-07 2014-12-31 Salix Pharmaceuticals Inc Podawanie środka czyszczącego jelito i antybiotyku w leczeniu choroby jelit
US8524691B2 (en) 2008-08-13 2013-09-03 The Medicines Company Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
DK2327407T3 (da) 2008-09-26 2014-08-25 Aska Pharm Co Ltd Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme
SMT202400116T1 (it) 2008-10-02 2024-05-14 Salix Pharmaceuticals Ltd Trattamento dell’encefalopatia epatica utilizzando rifaximina
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
US8916193B2 (en) 2008-12-10 2014-12-23 Cipla Limited Rifaximin complexes
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
BRPI1010028A2 (pt) 2009-06-02 2019-02-12 Salix Pharmaceuticals, Ltd. métodos de tratamento de encefalopatia hepática
WO2011032085A1 (en) 2009-09-13 2011-03-17 Salix Pharmaceuticals, Ltd. Methods for treating irritable bowel syndrome (ibs)
WO2011051971A2 (en) 2009-10-27 2011-05-05 Lupin Limited Solid dispersion of rifaximin
RU2012126084A (ru) 2009-11-23 2013-12-27 Сипла Лимитед Пенная композиция для местного применения
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
JP5896380B2 (ja) 2010-02-18 2016-03-30 サリックス ファーマスーティカルズ，リミテッド 感染症を治療するための方法
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
EP2544660B1 (en) 2010-03-10 2018-06-13 Lupin Limited Rifaximin ready-to-use suspension
HUE049986T2 (hu) 2010-07-12 2020-11-30 Salix Pharmaceuticals Inc Rifaximin készítmények és ezek alkalmazásai
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
WO2012109605A2 (en) 2011-02-11 2012-08-16 Salix Pharmaceuticals, Ltd. Forms of rifaximin and uses thereof
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) * 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
EP2773205B1 (en) 2011-11-02 2024-05-22 Salix Pharmaceuticals, Inc. Rifaximin for retreating diarrhea-predominant irritable bowel syndrome
AU2013212008A1 (en) 2012-01-25 2014-07-10 Alfa Wassermann S.P.A. Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
JP2016516988A (ja) 2013-03-15 2016-06-09 アルファ ワッセルマン ソシエタ ペル アチオニＡｌｆａ Ｗａｓｓｅｒｍａｎｎ Ｓ．Ｐ．Ａ． 膣感染症を診断するための方法
EA201591267A1 (ru) 2013-03-15 2016-03-31 Альфа Вассерманн С.П.А. Рифаксимин для применения в лечении вагинальных инфекций
AU2014252219B2 (en) 2013-04-12 2018-11-22 Alfasigma S.P.A. NSAID administration and related compositions, methods and systems.
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
WO2015159275A2 (en) * 2014-04-19 2015-10-22 Granules India Limited An improved process for the preparation of rifamycin derivatives
MX375805B (es) 2014-05-04 2025-03-07 Salix Pharmaceuticals Inc Microbiota ibs y sus usos.
PT3546464T (pt) 2014-05-12 2020-08-05 Alfasigma Spa Preparação e utilização da forma cristalina tau de rifaximina solvatada com degme
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
PL3518924T3 (pl) 2016-09-30 2023-01-09 Salix Pharmaceuticals, Inc. Postacie stałej dyspersji ryfaksyminy
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine
HUE054832T2 (hu) * 2017-06-26 2021-10-28 Biofer Spa Pirido-imidazo rifamicinszármazékok baktériumellenes szerként
CN116018133A (zh) 2020-06-26 2023-04-25 博士医疗爱尔兰有限公司 靶向释放利福昔明组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (it) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
JPS5711987A (en) 1982-01-21
ES502906A0 (es) 1982-04-01
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
AU7065581A (en) 1981-11-26
NO155622B (no) 1987-01-19
IT1154655B (it) 1987-01-21
ES8203388A1 (es) 1982-04-01
GR75640B (it) 1984-08-02
DK157876C (da) 1990-07-30
PH18704A (en) 1985-09-05
NL187022B (nl) 1990-12-03
IE811139L (en) 1981-11-22
SE453089B (sv) 1988-01-11
NL187022C (nl) 1991-05-01
AR226212A1 (es) 1982-06-15
DK157876B (da) 1990-02-26
DE3120460C2 (it) 1990-12-13
EG14891A (en) 1985-12-31
GB2079270A (en) 1982-01-20
FR2482967B1 (it) 1985-03-29
CA1142518A (en) 1983-03-08
PH17207A (en) 1984-06-19
JPS6123192B2 (it) 1986-06-04
IE51204B1 (en) 1986-10-29
ATA222781A (de) 1983-06-15
AU537093B2 (en) 1984-06-07
NO811731L (no) 1981-11-23
FI69467C (fi) 1986-02-10
FI811565L (fi) 1981-11-23
DK224781A (da) 1981-11-23
FI69467B (fi) 1985-10-31
NO155622C (no) 1987-04-29
AT373599B (de) 1984-02-10
CH648037A5 (de) 1985-02-28
LU83376A1 (fr) 1981-09-11
ZA813430B (en) 1982-06-30
FR2482967A1 (fr) 1981-11-27
NL8102290A (nl) 1981-12-16
US4341785A (en) 1982-07-27
GB2079270B (en) 1984-01-18
BE888895A (fr) 1981-09-16
DE3120460A1 (de) 1982-03-11
PT73064A (en) 1981-06-01

Similar Documents

Publication Publication Date Title
IT1154655B (it) Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1119284B (it) Derivati carbostirilici e procedimento per la loro preparazione
IT1141057B (it) Derivati di deformiltilosina e loro preparazione
IT8222769A0 (it) Composti tetrakisazo derivati e procedimenti per la loro preparazione ed uso
IT1130489B (it) Derivati chinonici particolarmente utili come medianti e procedimento per la loro preparazione
IT1123120B (it) Cefem derivati e procedimento per la loro preparazione
IT1164735B (it) Derivati adenosinici e procedimento per la loro preparazione
IT1164076B (it) Composti farmaceutici ad azione antiulcera e procedimento per la loro preparazione
IT7969010A0 (it) Derivati di benzotiepinici e procedimento per la loro preparazione
IT1165368B (it) Nuovi cefem derivati ad azione antimicrobica e procedimento per la loro preparazione
IT1147741B (it) Derivati di idrossiammino eburnano e procedimento per la loro preparazione
IT1132403B (it) Derivati di alovincamone e procedimento per la loro preparazione
IT1113203B (it) Derivati steroideo-spiro-ossazolidinonici sostituiti e procedimento per la loro preparazione
IT1106130B (it) Derivati di 24-deidrovitamina d3 e loro preparazione
IT1143701B (it) Derivati aril-idrazonici,loro uso come pesticidi e loro preparazione
IT1135629B (it) N-imidzolil derivati di 1-cromano e procedimento per la loro preparazione
IT1132404B (it) Derivati di 10-alo-e-omoeburnano e procedimento per la loro preparazione
IT1127336B (it) Derivati della cefalosporina loro preparazione e loro impiego
IT1169903B (it) Derivati epossicarbaciclinici, loro preparazione e loro uso
IT1174735B (it) Derivati di tunicamina di attivita antibatterica e loro metodo di preparazione
IT8303354A0 (it) Derivati carbomoil-rifamicinici,metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203626A0 (it) Nuovi derivati imidazorifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203360A0 (it) Nuovi derivati carbamoilrifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8119666A0 (it) Derivati benzilidenici,loro preparazione e loro applicazioni in terapia
IT8119566A0 (it) Derivati della prostaciclina,loro preparazione e impiego

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 46

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 46, 19920304; ALFA WASSERMANN S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423